Johnson & Johnson vs. Parabilis Medicines, Inc. Common Stock
Johnson & Johnson (JNJ) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| JNJ | PBLS | |
|---|---|---|
| Market Cap | $641.07 billion | $3.09 billion |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| JNJ | PBLS | |
|---|---|---|
| Dividend Yield | 1.99% | — |
JNJ and PBLS split the dividend factors evenly.
Risk & Sentiment
| JNJ | PBLS | |
|---|---|---|
| Short Interest | 0.67% | 0.90% |
JNJ leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, PBLS overview, PBLS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.